MiR-31 is an independent prognostic factor and functions as an oncomir in cervical cancer via targeting ARID1A

Gynecologic Oncology

Volumn 134, Issue 1, 2014, Pages 129-137

  Wang, Nan ^a   Zhou, Yun ^b   Zheng, Lijuan ^a   Li, Hui ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b Wu Han Tumor Hospital   (China)

Author keywords

ARID1A; Cell metastasis; Cell proliferation; Cervical cancer; miR 31

Indexed keywords

MICRORNA 31; PROTEIN; PROTEIN ARID1A; UNCLASSIFIED DRUG; ARID1A PROTEIN; SMALL INTERFERING RNA;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; ASSAY; CANCER PROGNOSIS; CELL CYCLE; CELL MIGRATION; CELL PROLIFERATION; CERVICAL CANCER CELL LINE; COLONY FORMATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LUCIFERASE ASSAY; METASTASIS; MOUSE; NONHUMAN; OVERALL SURVIVAL; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; TUMOR GROWTH; UPREGULATION; UTERINE CERVIX CANCER; WOUND HEALING; XENOGRAFT; CANCER INHIBITION; CANCER REGRESSION; CANCER STAGING; CANCER SURVIVAL; CANCER TISSUE; CELL INVASION; CLINICAL ARTICLE; FILTERS AND MEMBRANES; GENE EXPRESSION; GENE TARGETING; GENETIC ASSOCIATION; HEK293 CELL LINE; HELA CELL LINE; LYMPH NODE METASTASIS; MTT ASSAY; PROPORTIONAL HAZARDS MODEL; PROTEIN FUNCTION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR INVASION; TUMOR XENOGRAFT; VASCULAR DISEASE;

ARID1A; CELL METASTASIS; CELL PROLIFERATION; CERVICAL CANCER; MIR-31;

ADULT; ANIMALS; APOPTOSIS; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CELL MOVEMENT; DISEASE PROGRESSION; FEMALE; HEK293 CELLS; HELA CELLS; HETEROGRAFTS; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; MICRORNAS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NUCLEAR PROTEINS; TRANSCRIPTION FACTORS; UP-REGULATION; UTERINE CERVICAL NEOPLASMS;

EID: 84903186567     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2014.04.047     Document Type: Article

References (32)

1. A. Jemal, F. Bray, M.M. Center, J. Ferlay, E. Ward, and D. Forman Global cancer statistics CA Cancer J Clin 61 2011 69 90
2. A. Hildesheim, and S.S. Wang Host and viral genetics and risk of cervical cancer: a review Virus Res 89 2002 229 240 (Pubitemid 35351541)
3. M. Inui, G. Martello, and S. Piccolo MicroRNA control of signal transduction Nat Rev Mol Cell Biol 11 2010 252 263
4. J. Lu, G. Getz, E.A. Miska, E. Alvarez-Saavedra, J. Lamb, and D. Peck et al. MicroRNA expression profiles classify human cancers Nature 435 2005 834 838 (Pubitemid 40839735)
5. A. Ventura, and T. Jacks MicroRNAs and cancer: short RNAs go a long way Cell 136 2009 586 591
6. C.L. Bartels, and G.J. Tsongalis MicroRNAs: novel biomarkers for human cancer Clin Chem 55 2009 623 631
7. W.O. Lui, N. Pourmand, B.K. Patterson, and A. Fire Patterns of known and novel small RNAs in human cervical cancer Cancer Res 67 2007 6031 6043 (Pubitemid 47037482)
8. X. Wang, S. Tang, S.Y. Le, R. Lu, J.S. Rader, and C. Meyers et al. Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth PLoS One 3 2008 e2557
9. J.W. Lee, C.H. Choi, J.J. Choi, Y.A. Park, S.J. Kim, and S.Y. Hwang et al. Altered MicroRNA expression in cervical carcinomas Clin Cancer Res 14 2008 2535 2542
10. T. Tang, H.K. Wong, W. Gu, M.Y. Yu, K.F. To, and C.C. Wang et al. MicroRNA-182 plays an onco-miRNA role in cervical cancer Gynecol Oncol 129 2013 199 208
11. B. Muralidhar, D. Winder, M. Murray, R. Palmer, N. Barbosa-Morais, and H. Saini et al. Functional evidence that Drosha overexpression in cervical squamous cell carcinoma affects cell phenotype and microRNA profiles J Pathol 224 2011 496 507
12. Y. Li, F. Wang, J. Xu, F. Ye, Y. Shen, and J. Zhou et al. Progressive miRNA expression profiles in cervical carcinogenesis and identification of HPV-related target genes for miR-29 J Pathol 224 2011 484 495
13. Q. Rao, Q. Shen, H. Zhou, Y. Peng, J. Li, and Z. Lin Aberrant microRNA expression in human cervical carcinomas Med Oncol 29 2012 1242 1248
14. X. Liu, L.F. Sempere, H. Ouyang, V.A. Memoli, A.S. Andrew, and Y. Luo et al. MicroRNA-31 functions as an oncogenic microRNA in mouse and human lung cancer cells by repressing specific tumor suppressors J Clin Invest 120 2010 1298 1309
15. D. Sun, F. Yu, Y. Ma, R. Zhao, X. Chen, and J. Zhu et al. MicroRNA-31 activates the RAS pathway and functions as an oncogenic MicroRNA in human colorectal cancer by repressing RAS p21 GTPase activating protein 1 (RASA1) J Biol Chem 288 2013 9508 9518
16. S. Wang, Q. Li, K. Wang, Y. Dai, J. Yang, and S. Xue et al. Decreased expression of microRNA-31 associates with aggressive tumor progression and poor prognosis in patients with bladder cancer Clin Transl Oncol 15 2013 849 854
17. P.C. Lin, Y.L. Chiu, S. Banerjee, K. Park, J.M. Mosquera, and E. Giannopoulou et al. Epigenetic repression of miR-31 disrupts androgen receptor homeostasis and contributes to prostate cancer progression Cancer Res 73 2013 1232 1244
18. C. Chen, D.A. Ridzon, A.J. Broomer, Z. Zhou, D.H. Lee, and J.T. Nguyen et al. Real-time quantification of microRNAs by stem-loop RT-PCR Nucleic Acids Res 33 2005 e179
19. B. Zhou, R. Ma, W. Si, S. Li, Y. Xu, and X. Tu et al. MicroRNA-503 targets FGF2 and VEGFA and inhibits tumor angiogenesis and growth Cancer Lett 333 2013 159 169
20. N. Wang, T. Zhan, T. Ke, X. Huang, D. Ke, and Q. Wang et al. Increased expression of RRM2 by human papillomavirus E7 oncoprotein promotes angiogenesis in cervical cancer Br J Cancer 110 2014 1034 1044
21. P. Workman, E.O. Aboagye, F. Balkwill, A. Balmain, G. Bruder, and D.J. Chaplin et al. Guidelines for the welfare and use of animals in cancer research Br J Cancer 10 2010 1555 1577
22. A. Katagiri, K. Nakayama, M.T. Rahman, M. Rahman, H. Katagiri, and M. Ishikawa et al. Frequent loss of tumor suppressor ARID1A protein expression in adenocarcinomas/adenosquamous carcinomas of the uterine cervix Int J Gynecol Cancer 22 2012 208 212
23. H. Cho, J.S. Kim, H. Chung, C. Perry, H. Lee, and J.H. Kim Loss of ARID1A/BAF250a expression is linked to tumor progression and adverse prognosis in cervical cancer Hum Pathol 44 2013 1365 1374
24. W. Meng, Z. Ye, R. Cui, J. Perry, V. Dedousi-Huebner, and A. Huebner et al. MicroRNA-31 predicts the presence of lymph node metastases and survival in patients with lung adenocarcinoma Clin Cancer Res 19 2013 5423 5433
25. C.L. Cottonham, S. Kaneko, and L. Xu miR-21 and miR-31 converge on TIAM1 to regulate migration and invasion of colon carcinoma cells J Biol Chem 285 2010 35293 35302
26. P.B. Dallas, I.W. Cheney, D.W. Liao, V. Bowrin, W. Byam, and S. Pacchione et al. p300/CREB binding protein-related protein p270 is a component of mammalian SWI/SNF complexes Mol Cell Biol 18 1998 3596 3603 (Pubitemid 28240532)
27. Y. Jiao, T.M. Pawlik, R.A. Anders, F.M. Selaru, M.M. Streppel, and D.J. Lucas et al. Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas Nat Genet 45 2013 1470 1473
28. M. Le Gallo, A.J. O'Hara, M.L. Rudd, M.E. Urick, N.F. Hansen, and N.J. O'Neil et al. Exome sequencing of serous endometrial tumors identifies recurrent somatic mutations in chromatin-remodeling and ubiquitin ligase complex genes Nat Genet 44 2012 1310 1315
29. D.D. Wang, Y.B. Chen, K. Pan, W. Wang, S.P. Chen, and J.G. Chen et al. Decreased expression of the ARID1A gene is associated with poor prognosis in primary gastric cancer PLoS One 7 2012 e40364
30. B. Guan, and T.L. Wang Shih IeM. ARID1A, a factor that promotes formation of SWI/SNF-mediated chromatin remodeling, is a tumor suppressor in gynecologic cancers Cancer Res 71 2011 6718 6727
31. H.B. Yan, X.F. Wang, Q. Zhang, Z.Q. Tang, Y.H. Jiang, and H.Z. Fan et al. Reduced expression of the chromatin remodeling gene ARID1A enhances gastric cancer cell migration and invasion via downregulation of E-cadherin transcription Carcinogenesis 35 2014 867 876
32. K.C. Wiegand, S.P. Shah, O.M. Al-Agha, Y. Zhao, K. Tse, and T. Zeng et al. ARID1A mutations in endometriosis-associated ovarian carcinomas N Engl J Med 363 2010 1532 1543